p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: Possible implications for melanoma progression

Journal of the National Cancer Institute

Volumn 95, Issue 10, 2003, Pages 723-732

  Sviderskaya, Elena V ^a   Gray Schopfer, Vanessa C ^a   Hill, Simon P ^a   Smit, Nico P ^b   Evans Whipp, Tracy J ^a   Bond, Jane ^c   Hill, Lucy ^a   Bataille, Veronique ^d   Peters, Gordon ^e   Kipling, David ^c   Wynford Thomas, David ^c   Bennett, Dorothy C ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; ENDOTHELIN 1; PROTEIN P16; PROTEIN P53; RNA DIRECTED DNA POLYMERASE; STEM CELL FACTOR; TELOMERASE;

ALLELE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL IMMORTALIZATION; CELL PROLIFERATION; CHROMOSOME ABERRATION; CONTROLLED STUDY; CULTURE MEDIUM; DICENTRIC CHROMOSOME; FIBROBLAST; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KERATINOCYTE; LIFESPAN; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETROVIRUS; SENESCENCE; TELOMERE; VIRAL GENE DELIVERY SYSTEM; WART VIRUS;

EID: 0037941546     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/95.10.723     Document Type: Article

References (61)

1. Ruas M, Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1998;1378:F115-77.
2. Sharpless NE, DePinho RA. The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev 1999;9:22-30.
3. Rocco JW, Sidransky D. p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 2001;264:42-55.
4. Sherr CJ. The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2001;2:731-7.
5. Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumour suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995;83:993-1000.
6. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366: 704-7.
7. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, et al. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 1998;17:5001-14.
8. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997;91:649-59.
9. Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, et al. The INK4a tumor suppressor gene product, p19ARF, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 1998;92:713-23.
10. Zhang Y, Xiong Y, Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppressor pathways. Cell 1998;92:725-34.
11. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheaban MD, et al. Germline p16 mutations in familial melanoma. Nat Genet 1994;8:15-21.
12. Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, et al. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 2001;413:86-91.
13. Krimpenfort P, Quon KC, Mooi WJ, Loonstra A, Berns A. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 2001;413:83-6.
14. Zindy F, Quelle DE, Roussel MF, Sherr CJ. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 1997;15:203-11.
15. Wynford-Thomas D. Cellular senescence and cancer. J Pathol 1999;187: 100-11.
16. DePinho RA. The age of cancer. Nature 2000;408:248-54.
17. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997;88:593-602.
18. England NL, Cuthbert AP, Trott DA, Jezzard S, Nobori T, Carson DA, et al. Identification of human tumour suppressor genes by monochromosome transfer: rapid growth arrest mapped to 9p21 is mediated solely by the cyclin-D-dependent kinase inhibitor gene, CDKN2A (p16INK4A). Carcinogenesis 1996;17:1567-75.
19. Vogt M, Haggblom C, Yeargin J, Christiansen-Weber T, Haas M. Independent induction of senescence by p16INK4a and p21CIP1 in spontaneously immortalized human fibroblasts. Cell Growth Differ 1998;9:139-46.
20. Wei W, Hemmer RM, Sedivy JM. Role of p14ARF in replicative and induced senescence of human fibroblasts. Mol Cell Biol 2001;21:6748-57.
21. Serrano M, Lee HW, Chin L, Cordon-Cardo C, Beach D, DePinho RA. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996;85:27-37.
22. Medrano EE, Yang F, Boissy R, Farooqui J, Shah V, Matsumoto K, et al. Terminal differentiation and senescence in the human melanocyte: repression of tyrosine-phosphorylation of the extracellular signal-regulated kinase 2 selectively defines the two phenotypes. Mol Biol Cell 1994;5: 497-509.
23. Haddad MM, Xu W, Medrano EE. Aging in epidermal melanocytes: cell cycle genes and melanins. J Investig Dermatol Symp Proc 1998;3:36-40.
24. Bandyopadhyay D, Medrano EE. Melanin accumulation accelerates melanocyte senescence by a mechanism involving p16INK4a/CDK4/pRB and E2F1. Ann N Y Acad Sci 2000;908:71-84.
25. Bandyopadhyay D, Timchenko N, Suwa T, Hornsby PJ, Campisi J, Medrano EE. The human melanocyte: a model system to study the complexity of cellular aging and transformation in non-fibroblastic cells. Exp Gerontol 2001;36:1265-75.
26. Eisinger M, Marko O. Selective proliferation of normal human melanocytes in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci U S A 1982;79:2018-22.
27. Gilchrest BA, Vrabel MA, Flynn E, Szabó G. Selective cultivation of human melanocytes from newborn and adult epidermis. J Invest Dermatol 1984;83:370-6.
28. Graeven U, Herlyn M. In vitro growth patterns of normal human melanocytes and melanocytes from different stages of melanoma progression. J Immunother 1992;12:199-202.
29. Bennett DC, Medrano EE. Molecular regulation of melanocyte senescence. Pigment Cell Res 2002;15:242-50.
30. Gruis NA, van der Velden PA, Sandkuijl LA, Prins DE, Weaver-Feldhaus J, Kamb A, et al. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat Genet 1995;10:351-3.
31. Brookes S, Rowe J, Ruas M, Llanos S, Clark PA, Lomax M, et al. INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence. EMBO J 2002;21:2936-45.
32. Huot TJ, Rowe J, Harland M, Drayton S, Brookes S, Goopta C, et al. Biallelic mutations in p16INK4a confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts. Mol Cell Biol 2002;22:8135-43.
33. Pavel S, Smit NP, van der Meulen J, Kolb AM, de Groot A, van der Velden PA, et al. Homozygous germline mutation of CDKN2A/p16 and glucose-6-phosphate dehydrogenase deficiency in a multiple melanoma case. Melanoma Res 2003;13:171-8.
34. Blackburn EH. Telomere states and cell fates. Nature 2000;408:53-6.
35. Bodnar AG, Quellette M, Frolkis M, Holt SE, Chin CP, Morin GB, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998;279:349-52.
36. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ. Both RB/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998;396:84-8.
37. Ramirez RD, Morales CP, Herbert BS, Rohde JM, Passons C, Shay JW, et al. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev 2001;15:398-403.
38. Smit NP, Van der Meulen H, Koerten HK, Kolb RM, Mommaas AM, Lentjes EG, et al. Melanogenesis in cultured melanocytes can be substantially influenced by L-tyrosine and L-cysteine. J Invest Dermatol 1997; 109:796-800.
39. Bennett DC, Bridges K, McKay IA. Clonal separation of mature melanocytes from premelanocytes in a diploid human cell strain: spontaneous and induced pigmentation of premelanocytes. J Cell Sci 1985;77:167-83.
40. Navsaria HA, Sexton C, Bouvard V, Leigh IM. Growth of keratinocytes with a 3T3 feeder layer: basic techniques. In: Leigh IM, Watt F, editors. Keratinocyte methods. Cambridge (UK); Cambridge University Press; 1994. p. 5-12.
41. Sviderskaya EV, Bennett DC, Ho L, Bailin T, Lee ST, Spritz RA. Complementation of hypopigmentation in p-mutant (pink-eyed dilution) mouse melanocytes by normal human P cDNA, and defective complementation by OCA2 mutant sequences. J Invest Dermatol 1997;108:30-4.
42. Morgenstern JP, Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 1990;18:3587-96.
43. Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci U S A 1988;85:6460-4.
44. Miller DA, Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 1986;6:2895-902.
45. Imokawa G, Yada Y, Miyagishi M. Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. J Biol Chem 1992;267:24675-80.
46. Hachiya A, Kobayashi A, Ohuchi A, Takema Y, Imokawa G. The paracrine role of stem cell factor/c-kit signaling in the activation of human melanocytes in ultraviolet-B-induced pigmentation. J Invest Dermatol 2001;116: 578-86.
47. Morgenbesser SD, Williams BO, Jacks T, DePinho RA. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 1994;371:72-4.
48. MacLeod KF, Hu Y, Jacks T. Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J 1996;15:6178-88.
49. Gorospe M, Cirielli C, Wang X, Seth P, Capogrossi MC, Holbrook NJ. p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene 1997;14:929-35.
50. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci U S A 1996; 93:13742-7.
51. Bond J, Haughton M, Blaydes J, Gire V, Wynford-Thomas D, Wyllie F. Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence. Oncogene 1996;13:2097-104.
52. Montano X, Shamsher M, Whitehead P, Dawson K, Newton J. Analysis of p53 in human cutaneous melanoma cell lines. Oncogene 1994;9:1455-9.
53. Albino AP, Vidal MJ, McNutt NS, Shea CR, Prieto VG, Nanus DM, et al. Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res 1994;4:35-45.
54. Le Poole IC, Boissy RE, Sarangarajan R, Chen J, Forristal JJ, Sheth P, et al. PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum. In Vitro Cell Dev Biol Anim 2000; 36:309-19.
55. Zepter K, Häffner AC, Trefzer U, Elmets CA. Reduced growth factor requirements and accelerated cell cycle kinetics in adult human melanocytes transformed with SV40 large T antigen. J Invest Dermatol 1995;104: 755-62.
56. Bond JA, Haughton MF, Rowson JM, Smith PJ, Gire V, Wynford-Thomas D, et al. Control of replicative life span in human cells: barriers to clonal expansion intermediate between M1 senescence and M2 crisis. Mol Cell Biol 1999;19:3103-14.
57. Sviderskaya EV, Hill SP, Evans-Whipp TJ, Chin L, Orlow SJ, Easty DJ, et al. p16Ink4a in melanocyte senescence and differentiation. J Natl Cancer Inst 2002;94:446-54.
58. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949-54.
59. Clark WH, Elder DE, Guerry D, Braitman LE, Trock BJ, Schultz D, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989;81:1893-904.
60. Easty DJ, Bennett DC. Protein tyrosine kinases in malignant melanoma. Melanoma Res 2000;10:401-11.
61. Halachmi S, Gilchrest BA. Update on genetic events in the pathogenesis of melanoma. Curr Opin Oncol 2001;13:129-36.